top of page
  • Writer's pictureRobert O Young DSc, PhD, Naturopathic Practitioner

COVID VaXXXine Publications and Case Reports Citing Adverse Effects Post COVID VaXXXination!

Scientific Publications & Case Reports

The following is a collection of peer reviewed case reports and studies citing adverse effects post COVID vaccination!

Big Harma's "safe and effective" narrative is falling apart!

Please Do YOUR Homework and Learn and Understand Based Upon Real Science and NOT Scientism That the Increase or Excess Injuries and Deaths Are Being Caused by Graphene Poisoning and Pulsating Microwave Radiation!

The Bioeffects of Wireless Radiation Exposure and the Relationship to the Symptoms Called CoVid - 19

Read the entire article in the following PDF!

Download PDF • 646KB

Before Doing YOUR Deep Dive Into 1750 Plus Peer-reviewed Scientific Articles on the Real Cause of SARS - CoVid - 19 Please WATCH the Following Interview of Dr. Robert O. Young and Dr. Ariyana Love!

Transhuman Nightmare Graphene Nanowires Torturing the VaXXed and the UNVaXXed Around the World!

The Effects of Electro-Magnetic Frequencies (EMF) on the Blood and Biological Terrain

Excess VaXXine Neurological Injuries:

General Neuro side effects:

Small fiber neuropathy:

2 cases of Parsonage Turner Syndrome following Moderna and Pfizer:

Trigeminal Neuralgia and cervical radiculitis after Pfizer:

Neuralgic amyotrophy following mRNA vaccination:

Amyotrophic neuralgia secondary to AstraZeneca:

36yoM with transverse myelitis following AstraZeneca:

Acute Myelitis following AstraZeneca:

67yoF with transverse myelitis following Moderna 1st dose:

Longitudinal extensive transverse myelitis following AstraZeneca:

Transverse Myelitis and Bells Palsy after J&J vaccination:

Recurrent GBS following mRNA vaccination:

GBS following Johnson and Johnson:

4 cases of GBS following Astra Zeneca:

GBS following 2nd dose of Pfizer:

GBS after the first dose of Pfizer:

GBS in a 25yoF following 2nd dose of Pfizer:

GBS in a 61yoM following Moderna:

GBS in a 65yoM liver transplant patient following Pfizer:

GBS in a 73yoM following Moderna:

GBS in 73yoM following 2nd dose of Pfizer:

GBS in 82yoF following 1st dose Pfizer:

GBS 10 days after AstraZeneca:

GBS 11 days after AstraZeneca:

GBS following AstraZeneca:

7 cases of GBS following AstraZeneca:

GBS following AstraZeneca with papilledema as atypical onset:

2 cases of Sensory GBS following AstraZeneca:

Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca:

Bifacial diplegia variant of GBS following J&J vaccination:

Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna:

Transient akathisia after Pfizer:


21yoF nurse with Bells Palsy following Pfizer:

34yoF with Bells Palsy 2 days after Moderna:

36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination:

37yoM with Bells Palsy after Pfizer:

50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days:

57yoF with Bells Palsy <36 hours after 2nd dose of Pfizer:

61yoM with Bells Palsy after each dose of Pfizer:

Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested case-control study:

Rate of Bells Palsy following mRNA vaccination is 2-3x higher then expected:

Neuromyelitis optica spectrum disorder (NMOSD):

Patient’s first MS Flare following Pfizer:

4 cases of activation of stable MS, 2 cases of new MS, 1 case of new onset neuromyelitis optica after mRNA vaccination:

Severe Multiple Sclerosis relapse after Pfizer:

Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination:

Myasthenia Gravis Flare Following Moderna:

CVA and Thrombocytopenia following Astrazeneca:

Central venous sinus thrombosis with subarachnoid hemorrhage in a 45yoM following Moderna:

Cerebral venous thrombosis and pulmonary embolus following AstraZeneca:

Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management:

Cerebral venous sinus thrombosis, subarachnoid hemorrhage, and thrombocytopenia following AstraZeneca:

Cerebral Venous sinus thrombosis, review of European cases:

Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca:

A multicenter cohort study of cerebral venous thrombosis after AstraZeneca Vaccination:

45 cases of Cerebral Venous thrombosis:

International Cerebral Venous Thrombosis consortium report on cerebral venous thrombosis following vaccination against SARS-COV-2:

Fatal ICH following AstraZeneca:

Treatment of AstraZeneca induced immume thrombotic thrombocytopenia related acute ischemic stroke:

Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination:

Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study:

Aseptic Meningitis following Pfizer:

Delirium in an elderly patient following Pfizer:

Delirium in an elderly patient following vaccination:

Two cases of encephalopathy and seizures following Moderna:

Acute disseminated encephalitis following Pfizer:

Acute Disseminated Encephalitis in a young female following mRNA vaccination:

Postvaccinal encephalitis following AstraZeneca:

Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine:

New onset psychosis in 31yoM after mRNA vaccine:

Severe dyskinesia in Parkinson Patient following mRNA vaccination:

Cytotoxic lesion of the Corpus Callousum following mRNA vaccination:

Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA vaccination:

Three cases: CVA, left facial nerve palsy, and myelitis all following AstraZeneca:

Headache after AstraZeneca: a MultiCenter observational cohort center:

Characteristics of COVID vaccine induced Headache:

Covid Vaccines are not free of Neurologic side effects:

Rebuttal about Functional Neurologic Disorders and Vaccination:

Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present:

Excess VaXXine Cardiac Injuries:

Myocarditis in 23 military members:

Perimyocarditis in teens:

Vaccination associated myocarditis in Adolescents:

mRNA vaccination and myocarditis in adolescents:

Association of myocarditis with mRNA vaccination, a case review in children:

Recurrence of myocarditis after vaccination:

Myopericarditis in young adults presenting to the ED:

Pericarditis following mRNA vaccination:

Myocarditis following J&J in a healthy, young male:

Acute myocarditis after Moderna in young male:

Myocarditis in a healthy male:

Acute myocarditis following vaccination:

Acute myocarditis following Pfizer in a healthy man with previous COVID infection:

Myocarditis case report:

Myocarditis following mRNA vaccination:

Myocarditis in 24yoM:

Myocarditis in a 24yoM nurse after Pfizer:

Myocarditis in a 15yo following Pfizer:

Myopericarditis in a 16yo following vaccination:

Myocarditis in a 22yoM following Moderna:

70yoF with myocarditis following J&J Vaccination:

Biopsy proven lymphocytic myocarditis following 1st mRNA vaccination in a 40yo:

Cardiac imaging of acute myocarditis following mRNA in a 24yoM:

Cardiac MRI findings in young adults following mRNA vaccination: a case series:

Myopericarditis following mRNA vaccination: the role of cardiac biomarkers and multimodality imaging:

Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination:

Myocarditis Associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings:

Fulminant myocarditis and systemic hyperinflammation in 2 patients following mRNA:

2 cases of histological confirmed myocarditis following mRNA vaccination:

Myocarditis and Pericarditis: 2 case reports:

Two cases of myocarditis:

Two cases of myocarditis:

3 cases of cardiac manifestation following Pfizer:

4 cases of Myocarditis and their Cardiac MRI findings:

4 cases of myocarditis:

6 cases of men age 17-37 with myocarditis:

8 cases of myocarditis in adolescents following Pfizer:

13 cases of Myocarditis in adolescents following Pfizer:

Review of 15 published cases of myocarditis:

Review of 29 published cases of acute myopericarditis following mRNA vaccination:

Review of 214 myocarditis cases:

JAMA article, concerns for perimyocarditis underreporting, review of 40 hospitals:

Intravenous injection of mRNA vaccine can induce acute myopericarditis in mouse model:

The Novel platform of mRNA vaccines and myocarditis - clues into the potential underlying mechanism:

3 cases of acute infarct-like myocarditis (2 Pfizer, 1 AstraZeneca):

2 cases of acute MI <24 hours after mRNA vaccination:

Acute STEMI MI following AstraZeneca vaccination,?Kounis syndrome?:

Vaccine induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction following AstraZeneca:

Frequent PVS and NSVT following 2nd dose of Pfizer:

Isolated tachycardia in a 29yoF following Pfizer:

Covid-19 vaccine associated Takotsubo cardiomyopathy:

63yoF with Takotsubo cardiomyopathy following Moderna:

Tachycardia following Pfizer: 3 cases in those previously infected with COVID-19:

Dizziness, HTN and new LBBB following AstraZeneca vaccination:

Excess VaXXine Gastrointestinal Injuries:

Gastroparesis following Pfizer:

Acute Necrotizing Pancreatitis following 2nd dose of Pfizer:

Acute Pancreatitis in a 96yoF following 1st dose of Pfizer:

Cutaneous hypersensitivity reaction with acute hepatitis following Pfizer 2nd dose:

41yo F with Autoimmune hepatitis following Moderna:

76yoF with autoimmune hepatitis following Moderna Vaccination:

71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna):

80yoF with autoimmune hepatitis following Pfizer:

63yoM with autoimmune hepatitis following Moderna:

61yoF with liver injury following Pfizer:

35yoF with autoimmune hepatitis following Pfizer:

New Onset autoimmune hepatitis following mRNA vaccination in a 36yoF with Primary Sclerosing Cholangitis:

56yoF with autoimmune hepatitis following Moderna:

Two cases of autoimmune hepatitis following AstraZeneca:

Liver injury in a liver transplant patient following mRNA vaccination:

16 cases of liver injury following Pfizer and Moderna: a multicenter case series:

Reactivation of Hepatitis C infection following Pfizer in a 82yoF:

Unusual fever, HA, and abdominal pain in a healthy woman following AstraZeneca:

Hepatic vein thrombosis due to TTS following AstraZeneca:

Excess VaXXine Renal Injuries:

ANCA glomerulonephritis after Moderna:

New onset ANCA vasculitis after Pfizer:

ANCA associated Glomerulonephritis following Pfizer:

Nephrotic Syndrome following AstraZeneca:

New onset Nephrotic syndrome following J&J:

Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca:

De novo vasculitis after Moderna:

ANCA associated vasculitis following AstraZeneca:

IgA and crescentic glomerulonephritis following Pfizer:

Minimal Change Disease Following Pfizer:

Minimal Change Disease relapse following Pfizer:

MCD relapse following Pfizer:

MCD relapse following Pfizer:

Severe MCD relapse 3 days following Pfizer:

Minimal change disease and AKI following Pfizer:

Minimal Change disease following Moderna:

Minimal Change disease and Severe AKI following AstraZeneca:

3 cases of minimal change disease following 2nd dose of mRNA vaccine:

IgA nephropathy in 2 pediatric patients after Pfizer:

3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine:

2 cases of IgA nephropathy patients developing exacerbations following moderna:

IgA nephropathy flare up following Moderna:

IgA Nephropathy after mRNA vaccine:

2 cases of IgA Nephropathy patients developing hematuria after Pfizer:

Reactivation of IgA vasculitis following Moderna:

IgA vasculitis following AstraZeneca:

IgA nephropathy flare-up following vaccination:

Membranous nephropathy following mRNA vaccination:

Membranous nephropathy following Pfizer:

Renal Thrombotic Microangiopathy following Pfizer in a 35yoM:


Lupus exacerbation:

Lupus exacerbation following mRNA vaccination:

Systemic lupus following vaccination:

Relapse of class V lupus. Nephritis after mRNA vaccination:

Subacute cutaneous lupus erythematosus flare triggered by Moderna:

Emergence of new onset SLE following vaccination:

Hyperglycemic crisis:

Perturbation of blood glucose following vaccination, a review of 20 adults:

Subacute Thyroiditis:

Two cases of subacute thyroiditis after Moderna and AstraZeneca:

Two cases of Graves disease following vaccination:

Two more cases of Graves disease following Pfizer:

5 cases of adrenal crisis following AstraZeneca:

Myositis in a 56yoF following mRNA vaccination:

mRNA induced rhabdomyolysis and fasciitis:

Rhabdomyolysis after Moderna:

21yoM with Pfizer induced rhabdomyolysis:

Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination:

Rash, arthritis, swelling, muscle weakness following AstraZeneca:

Polyarthralgia and Myalgia syndrome after AstraZeneca:

40yoF with Henoch-Schonlein Purpura following Pfizer:

New onset mainly guttate psoriasis after Pfizer:

2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac:

14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca):

Pustuluar psoriasis following AstraZeneca:

Psorasis exacerbation after AstraZeneca:

Arthritis in the L elbow following vaccination:

Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination:

Remitting seronegative symmetrical synovitis with pitting edema following Pfizer:

Scleroderma renal crisis following mRNA vaccination:

Adult onset Still’s disease following AstraZeneca:

Adult onset Still’s disease following mRNA vaccine:

Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still’s disease:

Immune mediated disease flares:

Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis:

Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission:

11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination:

Excess VaXXine Hematological Injuries:

Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca:

Autoimmune hemolytic anemia:

Autoimmine hemolytic anemia following Pfizer:

ITP and AIHA following Moderna:

ITP Exacerbation in 12% of chronic patients:

ITP Exacerbation in previous stable patient following Pfizer:

ITP following Pfizer:

ITP following Pfizer:

Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer:

ITP and diffuse papular rash following Moderna:

ITP following Astrazeneca:

ITP in 1st trimester of pregnancy 13 days following vaccination in the US:

84yoM with ITP following Pfizer:

41yoF with ITP following Pfizer:

69yoF with refractory ITP following Pfizer:

20yoF with ITP following Pfizer:

54yoF with ITP following Pfizer:

74yoM with ITP following Moderna:

26yoF with ITP and acute liver injury following Moderna:

26yoF with ITP following Moderna:

63yoF with ITP following Johnson and Johnson:

68yoF with ITP following Moderna:

86yoM with ITP following AstraZeneca:

41yoM with ITP following AstraZeneca:

3 cases of ITP following Pfizer and Astra Zeneca:

3 cases reports of ITP following Pfizer and J&J:

3 cases: recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna:

3 cases of ITP in elderly patients following vaccination:

36 Cases of ITP following Pfizer and Moderna:

PE, TIA, and thrombocytopenia after J&J:

DVT and PE and positive HIT panel following mRNA Vaccine:

3 patients with venous thromboembolism following mRNA vaccination:

Thrombosis with Thrombocytopenia following Moderna:

TTP Following Pfizer:

Acquired TTP following Pfizer:

TTP in an adolescent following Pfizer:

Thrombocytopenia in a teen with sickle cell disease following Pfizer:

Safety warning for AstraZeneca in patients with sickle cell disease:

5 cases of prothrombotic immune thrombocytopenia after AstraZeneca:

20 cases of Thrombocytopenia following Pfizer and Moderna:

Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna:

68yoF with extensive thrombosis after AstraZeneca:

Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings:

Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca:

Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca:

Confusion and abdominal pain due to VITT following vaccination:

Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca:

Malignant CVA due to VITT following AstraZeneca:

3 cases of immune thrombocytopenia following AstraZeneca in Thailand:

Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination:

Successful venous thromboprophylaxis in a patient with AstraZeneca induced VITT:

Autoimmunity roots of the thrombotic events following COVID vaccination:

Thrombosis post COVID-19 Vaccinations

Potential link to ACE pathways:

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with AstraZeneca:

The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopenia:

Skin, nose, and gingival bleeding episodes after AstraZeneca: a large population-based cohort study:

Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination:

3 cases of HLH following AstraZeneca:

Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways:

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia:

Excess VaXXine Injuries and Oncology

Axillary lymphadenopathy following mRNA vaccination:

Ipsilateral axillary adenopathy following mRNA vaccination:

4 cases of axillary adenopathy following mRNA vaccination:

Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient:

163 cases of axillary adenopathy following Pfizer:

Incidence of axillary adenopathy on Breast Imaging following Vaccination:

Supraclavicular lymphadenopathy following Pfizer:

Cervical lymphadenopathy following Pfizer:

13 cases of Cervical lymphadenopathy:

50yoM with adenopathy following Pfizer:

Review of 24 cases of lymphadenopathy and their ultrasound findings in the US:

Kikucki-Fujimoto disease following Pfizer:

Mammographic and sonographic findings in the breast and axillary tail following vaccination:

Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI:

Evolution of lymphadenopathy at PET/MRI after vaccination:

Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy:

DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson:

DOTATOC-avid lymphadenopathies induced by mRNA vaccination:

3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT:

FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma:

Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination:

Vaccination effect on tracer uptake with FDG-PET/CT:

Abnormal PET following vaccination:

Positive PET following vaccination:

False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer:

The day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management:

Temporal metabolic response to mRNA vaccinations in oncology patients:

Thymic hyperplasia after mRNA vaccination:

Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient:

Moderna vaccination mimicking lymph-node progression in a patient with melanoma:

Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy:

Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma:

Excess VaXXine Injuries in Dermatology/Plastic Surgery

60yo with Steven Johnson Syndrome:

Steven Johnson Syndrome following Pfizer:

Pemphigus Vulgaris:

Morbilliform Rash:

Pityriasis-rosea like eruption post-vaccination in a young male:

Pityriasis rosea following Pfizer:

66yoM with Pityriasis rosea after Pfizer:

1 case of Pityriasis rosea and 3 cases of urticaria following Pfizer:

A case series of Pityriasis rosea following vaccination:

Two cases of papulo-pustular rosacea-like eruptions following Pfizer and AstraZeneca:

Pityriasis rubra pilaris following Astra Zeneca:

Pityriasis rubra pilaris in 72yoM following Astra Zeneca:

Pityriasis Rubra Pilaris like eruption following Pfizer:

3 cases of new onset acral hand lesions following mRNA vaccine:

2 patients with eczematous cutaneous reactions following Pfizer:

New onset synovitis and palmoplantar psoriasis flare up after Pfizer:

Exacerbation of Hailey-Hailey Disease following mRNA vaccination:

New onset lichen planus following Pfizer:

Lichen striatus:

Purpura annularis telangiectodes following Pfizer:

Flagellate Purpura following AstraZeneca:

Symmetrical drug related intertriginous and flexural exanthema like eruption following AztraZeneca:

Vitiligo following Pfizer:

Vitiligo in a Ulcerative Colitis Patient following mRNA vaccination:

Bacillus Calmette-Guerin scar flare after mRNA vaccination:

Palms and Soles Itchiness following Pfizer:

Resistant pruritis skin rash following Pfizer:

Necrotic eschars at injection sites one week after 2nd dose of Pfizer:

Facial Pustular Neutrophilic Eruption following mRNA vaccine:

Acute generalized exanthematous pustulosis induced by Moderna:

AstraZeneca induced acute localized exanthematous pustulosis:

Delayed local skin reactions:

Delayed skin reactions following mRNA vaccine:

11 patients with delayed skin reaction after mRNA vaccination:


12 Patients with Delayed Local Reactions:

16 patients delayed hypersensitivity reactions after Moderna:

138 Delayed Hypersensitivity Reactions following vaccination:

Delayed local Hypersensitivity reactions: a 6 month retrospective study:

Delayed cutaneous hypersensitivity reaction following AstraZeneca:

Cutaneous skin manifestation following Moderna with Hypersensitivity reaction Histopathology:

2 cases of delayed local reactions following Moderna:

4 cases of cutaneous hypersensitivity reactions following Moderna:

5 Japanese cases of delayed large local reactions to Pfizer vaccination:

13 cases delayed local reactions following mRNA vaccine:

COVID Vaccine arm:

COVID arm following Moderna: histologic features:

Covid vaccine arm may present after both mRNA vaccines vaccination:

405 cases of dermatologic reactions following Pfizer, Moderna, and Astra Zeneca:

Erythema Migrans like rash after Moderna:

Bullous Drug Eruption Rash following Moderna:

Bullous eruption following Pfizer:

Bullous Fixed Drug Eruption following AstraZeneca:

Atypical erythema multiforme related to Pfizer vaccine:

Soft Tissue Filler Inflammatory Reaction after vaccination:

Immune Response to fillers and breast implants after vaccination:

Breast Implant seroma after mRNA vaccine:

L Breast Implant Capsular Contracture following Moderna vaccination:

COVID-toes after mRNA vaccination:

Leukoclastic vasculitis:

Urticarial Vasculitis following vaccination:

Urticarial Vasculitis:

Small vessel vasculitis after Astra Zeneca:

Cutaneous small vessel vasculitis following J&J:

Cutaneous lymphocytic vasculitis following mRNA vaccine:

Pfizer induced reactivation of varicella and resulting small vessel vasculitis:

2 cases of skin color discoloration following mRNA vaccination:

A case series of rare cutaneous adverse events following vaccination:

Moderna Vaccine Induced Skin Rash:

A Case series of Cutaneous vaccine reactions at Loma Linda University:

Clinicopathological features of cutaneous reactions after mRNA vaccines, 11 cases:

3 cases of vesiculobullous non-IgE-mediated cutaneous reactions to Pfizer:

A narrative review of cutaneous and hypersensitivity reactions:

SARS-CoV-2 Vaccines and the Skin:

Excess VaXXine Injuries and Ophthalmology:

Acute Macular Neuroretinopathy after AstraZeneca:

Acute macular neuroretinopathy following Pfizer:

Acute Central Serous Retinopathy after Pfizer:


Reduction of Visual Acuity following Pfizer:

Corneal graft rejection after Pfizer vaccination:

Bilateral Retinal Detachments 10 days after mRNA vaccination 22yoF:

Central Retinal Vein Occlusion occuring immediately after 2nd dose of mRNA vaccine:

Transient Oculomotor palsy following mRNA. Vaccine:

Anterior Uveitis following Pfizer:

21 cases of Uveitis following mRNA vaccination:

A case of bilateral arteritic anterior ischemic optic neuropathy and a case of bilateral acute zonal occult outer retinopathy after mRNA vaccination:

Vaccination and Bilateral Multifocal Choroiditis:

34yoM with bilateral multifocal choroiditis following 2nd dose vaccination:

Acute painless bilateral blurring of vision following Pfizer due to Vogt-Koyanagi-Hara disease:

Eyelid erythema after Pfizer vaccination:

Reactivation of herpes simplex keratitis following AstraZeneca vaccination:

2 cases of Ipsilateral zoster opthalmicus after Moderna and Johnson and Johnson:

Bilateral immune mediated keratolysis following AstraZeneca:

COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence?


3 cases of Tinnitus following mRNA vaccination:

18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer:

Tinnitus/cochleopathy following AstraZeneca:

Lipschutz ulcers after AstraZeneca:


Herpes Zoster following Moderna:

Herpes Zoster reactivation following Moderna:

Ramsy Hunt syndrome following mRNA vaccination:

A case series of Herpes Zoster following AstraZeneca:

2 cases of herpes zoster following Pfizer:

2 cases of herpes zoster in healthy young adults following vaccination:

3 cases of Herpes Zoster following Vaccination (Moderna and AstraZeneca):

3 cases of Herpes Zoster after covid vaccination in patients with chronic urticaria being treated with cyclosporine:

4 cases of Herpes Zoster (2 pfizer, 2 astrazeneca):

6 cases of Herpes Zoster following Pfizer:

A case of varicella-zoster virus after Pfizer:

Varicella zoster reactivation and mRNA vaccines as a trigger:

40 cases of HSV and VZV reactivation following mRNA vaccination:


Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V):

3 cases of Multisystem Inflammatory Syndrome after Pfizer:

Hypertension following mRNA vaccination:

POTS following Pfizer:

Vaccine induced interstitial lung disease in 86yoM after mRNA vaccine:

Vaccine induced interstitial lung disease:

Pulmonary Embolus following Moderna:

Concerns for Pfizer vaccine failure to wildtype variants after Delta and vaccine induced enhanced illness, as demonstrated in a mice model:

International call for vaccine adverse reaction investigation:

Concerns about the lipid nanoparticle in the mRNA contributing to adverse reactions:

Medscape Health Care Professional Adverse Reactions:

Facebook link to reactions:

Need More Scientific Evidence to Convince YOU That the Corona VaXXine is NOT Safe or Effective?

The following link below will take you to over 1250 Peer-reviewed publications that provide the scientific proof that the Corona VaXXine is NOT safe or NOT effective and is causing injury and death -

Please support the work, research and findings of Dr. Robert O. Young with your prayers and donations at:'

No donation is too small and will be appreciated and used for continuous research, publications and public education!

* * * As a special thank you for your donation, I will answer one health or lifestyle related question.

After your donation, please email me at:

Keep your question short and very specific. Please include your first and last name, phone number and email. Your question will be answered within 72 hours.

God bless YOU ALL! and Stay healthy and happy!

230 views1 comment
bottom of page